Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.14 - $0.22 $10,692 - $16,802
-76,375 Reduced 5.44%
1,326,654 $224,000
Q3 2022

Nov 14, 2022

BUY
$0.24 - $0.54 $9,031 - $20,321
37,632 Added 2.76%
1,403,029 $278,000
Q2 2022

Aug 12, 2022

BUY
$0.34 - $0.57 $24,507 - $41,086
72,081 Added 5.57%
1,365,397 $684,000
Q4 2021

Feb 11, 2022

SELL
$0.57 - $1.23 $23,140 - $49,934
-40,597 Reduced 3.04%
1,293,316 $782,000
Q3 2021

Nov 12, 2021

BUY
$0.92 - $1.18 $43,952 - $56,373
47,774 Added 3.71%
1,333,913 $1.29 Million
Q2 2021

Aug 13, 2021

BUY
$0.66 - $1.23 $138,048 - $257,271
209,164 Added 19.42%
1,286,139 $1.41 Million
Q1 2021

May 12, 2021

BUY
$0.54 - $1.79 $280,005 - $928,165
518,528 Added 92.85%
1,076,975 $1.01 Million
Q4 2020

Feb 12, 2021

BUY
$0.4 - $1.01 $22,988 - $58,045
57,471 Added 11.47%
558,447 $270,000
Q3 2020

Nov 13, 2020

SELL
$0.52 - $1.45 $85,250 - $237,718
-163,944 Reduced 24.66%
500,976 $392,000
Q2 2020

Aug 13, 2020

BUY
$0.33 - $0.66 $11,268 - $22,537
34,148 Added 5.41%
664,920 $357,000
Q1 2020

May 14, 2020

BUY
$0.33 - $0.89 $339 - $916
1,030 Added 0.16%
630,772 $225,000
Q4 2019

Feb 13, 2020

BUY
$0.51 - $1.26 $149,215 - $368,650
292,580 Added 86.78%
629,742 $441,000
Q2 2019

Aug 14, 2019

BUY
$1.26 - $2.23 $39,472 - $69,859
31,327 Added 10.24%
337,162 $438,000
Q1 2019

May 14, 2019

BUY
$2.02 - $3.22 $9,100 - $14,506
4,505 Added 1.5%
305,835 $645,000
Q4 2018

Feb 13, 2019

BUY
$2.1 - $3.21 $100,797 - $154,076
47,999 Added 18.95%
301,330 $677,000
Q3 2018

Nov 13, 2018

BUY
$2.25 - $4.8 $149,121 - $318,124
66,276 Added 35.43%
253,331 $886,000
Q2 2018

Aug 14, 2018

BUY
$3.2 - $4.7 $39,993 - $58,740
12,498 Added 7.16%
187,055 $598,000
Q3 2017

Nov 14, 2017

BUY
$4.5 - $5.65 $231,498 - $290,658
51,444 Added 41.79%
174,557 $912,000
Q2 2017

Aug 14, 2017

BUY
N/A
123,113
123,113 $640,000

About Adamis Pharmaceuticals Corp


  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.